Home

Speakers

Agenda

Innovations in cell and gene therapy

Realize your vision – from early CGT discovery to commercialization
Now available on-demand

 

 

In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get an insight into how cutting edge technologies, like high-content and 3D imaging, electroporation, and validated express flow cytometry analyses help overcome challenges in CGT development.

 Read More Below

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this online symposium. We may use the information to contact you about your account and let you know about related programs and products. You may opt-out at any time. This allows Technology Networks to keep these events free of charge for our readers.

 

 

 

Online Symposium Summary

Cell and gene therapies (CGT) are a promising approach to combat previously untreatable diseases. Although the principle to enhance the body’s immune system appears obvious, successful CGT development is a demanding and lengthy process.

In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get an insight into how cutting edge technologies, like high-content and 3D imaging, electroporation, and validated express flow cytometry analyses help overcome challenges in CGT development.

Attend this event to learn:

  • Apply imaging in target validation
  • Learn about new technologies in CGT
  • Upgrade IPC/QC & patient monitoring

 Speakers:

Juliana Dias, PhD
Juliana Dias, PhD
Head of GMP CAR T Production
Centre for Cell, Gene and Tissue Therapeutics
Cristina Conforti Andreoni
Cristina Conforti Andreoni, PhD
Portfolio Strategy Manager – Immunotherapy
Miltenyi Biotec
Zhaojun Yin
Zhaojun Yin, PhD
Senior Scientist - BioAnalytical Sciences
Genentech
Marsilius Mues, PhD
Marsilius Mues, PhD
R&D Group Leader - Assay Development Cellular Immunotherapy
Miltenyi Biotec
Antonio Perez-Martinez, MD, PhD
Antonio Perez-Martinez, MD, PhD
Head of Pediatric Hemato-Oncology and Hematopoietic Transplant Service
La Paz University Hospital
Rita Pfeifer, PhD
Rita Pfeifer, PhD
R&D Team Coordinator - Pre-clinical Development Cellular Immunotherapy
Miltenyi Biotec
Marty Giedlin, PhD
Marty Giedlin, PhD
Senior Vice President, Head, Technical Operations
Senti BioSciences
Mariam L. Ammari, MS
Mariam L. Ammari
Senior Project Director - Clinical Cell Engineering
MD Anderson Cancer Center
Nina Möker, PhD
Nina Möker, PhD
R&D Reagents Manager - Allogeneic Cellular Immunotherapy
Miltenyi Biotec
Prof. Evelyn Ullrich, PhD
Prof. Evelyn Ullrich, MD
Cellular Immunology Research Group
University Hospital Frankfurt am Main
Daniel Schäfer, PhD
Daniel Schäfer, PhD
R&D Team Coordinator - Pre-clinical Development Cellular Immunotherapy
Miltenyi Biotec
Rizwan Romee, MD
Rizwan Romee, MD
Associate Professor of Medicine
Harvard Medical School, Dana Farber Cancer Institute
Caroline Brandes
Caroline Brandes
Researcher – Early Drug Development
Miltenyi Biotec
Dr. Dominik Lock
Dr. Dominik Lock
R&D Group Leader – Early Drug Development
Miltenyi Biotec